A common genetic polymorphism (46 C to T substitution) in the 5'- untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level

Blood

Volumn 91, Issue 6, 1998, Pages 2010-2014

  Kanaji, Taisuke ^b   Okamura, Takashi ^a   Osaki, Koichi ^b   Kuroiwa, Mika ^b   Shimoda, Kazuya ^b   Hamasaki, Naotaka ^b   Niho, Yoshiyuki ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 12; COMPLEMENTARY DNA; GENE PRODUCT;

ALLELE; ARTICLE; ASIAN; BLOOD CLOTTING FACTOR 12 DEFICIENCY; CAUCASIAN; CHROMOSOME 5Q; GENE FREQUENCY; GENETIC POLYMORPHISM; HETEROZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOEMBOLISM; TRANSLATION INITIATION;

EID: 0032521229     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.6.2010     Document Type: Article

References (34)

1. Kluft C, Dooijewaard G, Emeis JJ: Role of the contact system fibrinolysis. Semin Thromb Hemost 13:50, 1987
2. Magnusson S, Sottruo-Jensen L, Petersen TE, Dudeke-Wojciechowska G, Claeys H: Homologous "kringle" structures common to plasminogen and prothrombin. Substrate specificity of enzymes activating prothrombin and plasminogen, in Ribbons DW, Brew K (eds): Proteolysis and Physiological Regulation, vol 11. New York, NY, Academic, 1976, p 203
3. Ratnoff OD, Colopy JE: A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest 34:602, 1955
4. Saito H: Contact factors in health and disease. Semin Thromb Hemost 13:36, 1987
5. Ratnoff OD, Busse RJ, Sheron R: The demise of John Hageman. N Engl J Med 279:420, 1963
6. Goodnough LT, Saito H, Ratnoff OD: Thrombosis or myocardial infarction in congenital clotting factors abnormalities and chronic thrombocytopenias: A report of 21 patients and a review of 50 previously reported cases. Medicine 62:248, 1983
7. Cool DE, Edgell CJS, Louie GV, Zoller MJ, Brayer GD, MacGillivray RTA: Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of β-factor XIIa. J Biol Chem 260:13666, 1985
8. Que BG, Davie EW: Characterization of a cDNA coding for human factor XII (Hageman factor). Biochemistry 25:1525, 1986
9. Tripodi M, Citarella F, Guida S, Galeffi P, Fantoni A, Cortese R: cDNA sequence coding for human coagulation factor XII (Hageman). Nucleic Acids Res 14:3146, 1986
10. Clark BJ, Cote H, Cool DE, Clark-Lewis I, Saito H, Pixley RA, Colman RW, MacGillivray RTA: Mapping of a putative surface-binding site of human coagulation factor XII. J Biol Chem 264:11497, 1989
11. Cool DE, MacGillivray RTA: Characterization of the human blood coagulation factor XII gene. J Biol Chem 262:13662, 1987
12. Royle NJ, Nigli M, Cool D, MacGillivray RTA, Hamerton JL: Structural gene encoding human factor XII is located at 5q33-qter. Somat Cell Mol Genet 14:217, 1988
13. Revak SD, Cochrane CG, Griffin JH: Structural changes accompanying enzymatic activation of human Hageman factor. J Clin Invest 54:619, 1974
14. Saito H, Ratnoff OD, Pensky J: Radioimmunoassay of human Hageman factor (factor XII). J Lab Clin Med 88:506, 1976
15. Gordon EM, Donaldson VH, Saito H, Su E, Ratnoff OD: Reduced titers of Hageman factor (Factor XII) in Orientals. Ann Intern Med 95:697, 1981
16. Kanaji T, Okamura T, Niho Y, Sugiyama M: Molecular analysis of a family with factor XII deficiency. Identification of 126 Arg to Prosubstitution. Blood 86:876a, 1995 (abstr)
17. Dati F, Barthels M, Conard J, Flückiger J, Girolami A, Hänseler E, Huber J, Keller F, Kolde H-J, Muller-Berghaus G, Samama M, Thiel W: Multicenter evaluation of a chromogenic substrate method for photometric determination of prothrombin time. Thromb Haemost 58: 856, 1987
18. Laurell, CB: Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15:45, 1966
19. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning. A Laboratory Manual, 2nd Ed. New York, Cold Spring Harbor Laboratory Press, 1989
20. Bernardi F, Marchetti G, Pinotti M, Arcieri P, Barnocini C, Papacchini M, Zepponi E, Urscino N, Chiarotti F, Mariani G: Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol 16:72, 1996
21. Lunghi B, Iacoviello L, Gemmati D, Dilasio MG, Castoldi E, Pinotti M, Castaman G, Redaelli R, Mariani G, Marchetti G, Bernardi F: Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma. Thromb Haemost 75:45, 1996
22. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and increase in venous thrombosis. Blood 88:3698, 1996
23. Cooper DN: Human gene mutations affecting RNA processing and translation. Ann Med 25:11, 1993
24. Eikenboom JCJ, Ploos van Amstel HK, Reitsma PH, Briet E: Mutations in severe type II von Willebrand's disease in the Dutch population: Candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messenger RNA. Thromb Haemost 68:448, 1992
25. Yamazaki T, Hamaguchi M, Katsumi A, Kagami K, Kojima T, Takamatsu J, Saito H: A Quantitative protein S deficiency associated with a novel nonsense mutation and markedly reduced levels of mutated mRNA. Thromb Haemost 74:590, 1995
26. Kozak M: The scanning model for translation: An update. J Cell Biol 108:229, 1989
27. Cai S-P, Eng B, Francombe WH, Olivieri NF, Kendall AG, Waye JS, Chui DHK: Two novel β-thalassemia mutations in the 5′ and 3′ noncoding regions of the β-globin gene. Blood 79:1342, 1992
28. Halbmayer W-M, Haushofer A, Schön R, Mannhalter C, Strohmer E, Baumgarten K, Fischer M: The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: Evaluation of the incidence of FXII deficiency among 300 healthy blood donors. Thromb Haemost 71:68, 1994
29. Schmeidler-Sapiro KT, Ratnoff OD, Gordon EM: Mitogenic effects of coagulation factor XII and factor XIIa on HepG2 cells. Proc Natl Acad Sci USA 88:4382, 1991
30. Gordon EM, Venkatesan N, Salazar R, Tang H, Schmeidler-Sapiro K, Buckley S, Warburton D, Hall FL: Factor XII-induced mitogenesis is mediated via a distinct signal transduction pathway that activates a mitogen-activated protein kinase. Proc Natl Acad Sci USA 93:2174, 1996
31. Lämmle B, Wuillemin WA, Huber I, Krauskopf M, Zürcher C, Pflugshaupt R, Furlan M: Thromboembolism and bleeding tendency in congenital factor XII deficiency-A study on 74 subjects from 14 Swiss families. Thromb Haemost 65:117, 1991
32. Halbmayer W-M, Mannhalter C, Feichtinger C, Rubi K, Fischer M: The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/or arterial thromboembolism. Thromb Haemost 68:285, 1992
33. Winter M, Gallimore M, Jones DW: Should factor XII assays be included in thrombophilia screening? Lancet 346:52, 1995
34. Koster T, Rosendaal FR, Briet E, Vandenbroucke JP: John Hageman's factor and deep-vein thrombosis: Leiden Thrombophilia study. Br J Haematol 87:422, 1994